- Home
- RCUS vs KSS Comparison
RCUS vs KSS Comparison
Compare RCUS & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | KSS |
|---|---|---|
| Founded | 2015 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.5B |
| IPO Year | 2018 | 1992 |
Fundamental Metrics
Financial Performance| Metric | RCUS | KSS |
|---|---|---|
| Price | $21.31 | $22.82 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 8 | 13 |
| Target Price | ★ $29.38 | $15.55 |
| AVG Volume (30 Days) | 2.1M | ★ 6.8M |
| Earning Date | 10-28-2025 | 11-25-2025 |
| Dividend Yield | N/A | ★ 2.15% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.73 |
| Revenue | $240,000,000.00 | ★ $15,751,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.45 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.50 | $6.04 |
| 52 Week High | $26.40 | $25.22 |
Technical Indicators
Market Signals| Indicator | RCUS | KSS |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 59.85 |
| Support Level | $20.35 | $21.91 |
| Resistance Level | $26.10 | $23.50 |
| Average True Range (ATR) | 1.48 | 1.41 |
| MACD | -0.61 | -0.04 |
| Stochastic Oscillator | 15.21 | 57.69 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About KSS Kohl's Corporation
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.